Skip to main content

DECODIFICANDO LAS INTERACCIONES MICROBIOTA-HOSPEDADOR QUE PROTEGEN LA SALUD METABOLICA

PID2023-150693OB-I00

•
Funding agency name Agencia Estatal de Investigación
Funding agency acronym AEI
Program Programa Estatal para Impulsar la Investigación Científico-Técnica y su Transferencia
Subprogram Subprograma Estatal de Generación de Conocimiento
Call Proyectos de I+D+i (Generación de Conocimiento y Retos Investigación)
Call year 2023
State Plan 2021-2023 Plan Estatal de Investigación Científica y Técnica y de Innovación
Beneficiary centre AGENCIA ESTATAL CONSEJO SUPERIOR DE INVESTIGACIONES CIENTIFICAS (CSIC)

Resultados relacionados

Resultados totales (Incluyendo duplicados): 2
Encontrada(s) 1 página(s)

DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

The gut microbiome connects nutrition and human health

  • Sanz Herranz, Yolanda
  • Cryan, John F.
  • Deschasaux-Tanguy, Mélanie
  • Elinav, Eran
  • Lambrecht, Rebekka
  • Veiga, Patrick
The gut microbiome has an undeniable role in mediating the health effects of the diet, given its ability to co-digest nutrients and influence nutrient signalling to multiple organ systems. As a suboptimal diet is a major risk factor for and contributor to disease, understanding the multidirectional interactions between the food we eat, the gut microbiome and the different body organ systems is crucial from a public health perspective. Indeed, this research area is leading to the refinement of nutritional concepts and strategies to optimize health through diet. In this Review, we provide an update on how dietary patterns and food intake shape gut microbiome features, the mode of action of diet-microorganism interactions on the immune, nervous and cardiometabolic systems and how this knowledge could explain the heterogeneity of dietary responses, and support food-based dietary guidelines and medical and precision nutrition. Finally, we discuss the knowledge gaps and research efforts needed to progress towards the integration of microbiome science with more precise dietary advice to leverage the role of nutrition in human health., The work of Y.S. is funded by the Spanish Ministry of Science, Innovation and Universities (grant PID2023-150693OB-I00), and a “Severo Ochoa” grant of the National Agency for Research (AEI)–Spanish Ministry of Science and Innovation (ref. CEX2021-001189-S). The work of P.V. is funded in part by a Metagenopolis grant (ANR-11-DPBS-0001) and the PEPR-SAMS Cohortes-Microbiomes Project (ANR-24-PESA-0005). J.F.C. is supported by Science Foundation Ireland (SFI/12/RC/2273_P2), Saks Kavanaugh Foundation and Swiss National Science Foundation (CRSII5_186346/NMS2068). E.E. is supported by the European Union Thrive and Nutriome Consortiums and is a partner, Novo Nordisk Foundation Microbiome Health Initiative (MHI). R.L. is grateful to the Azrieli Foundation for an Azrieli Fellowship., With funding from the Spanish government through the ‘Severo Ochoa Centre of Excellence’ accreditation (CEX2021-001189-S)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Gut microbiota and immunometabolism in obesity

  • Torres Mayo, Alba
  • Liébana García, Rebeca
  • Olivares, Marta
  • Pellón, Aize
  • Anguita, Juan
  • Sanz Herranz, Yolanda
The gut microbiota plays a central role in modulating both immunity and metabolism. Obesity-associated microbiota configuration is a critical driver of persistent inflammatory activation and immune dysfunction, ultimately leading to chronic metabolic disorders. Immunometabolism examines how metabolic demands shape immune cell function and how immune responses influence cellular metabolism. Emerging research on how the gut microbiota contribute to immune cell metabolic processes and the resulting health outcomes is deepening our understanding of the mechanisms underlying obesity and metabolic diseases. In this review, we summarize how intracellular metabolic pathways and master regulators, such as mTOR and AMPK, orchestrate immune cell function and how their dysregulation contributes to obesity-associated immune and metabolic dysfunction. We also discuss how gut microbiota influences the immunometabolism of different myeloid and lymphoid cell subsets and intestinal epithelial cells. Finally, we review the role of microbially produced metabolites, including short-chain fatty acids, lactate, succinate, bile acids, and amino acids, in reprogramming immune cell metabolism. We also discuss whether modulating gut microbiota function to regulate immunometabolic pathways could help restore immune homeostasis and reduce obesity-related complications., This study has been funded by the Spanish Ministry of Science, Innovation and Universities (MCIU; grant PID2023-150693OB-I00 to YS, PID2024-155763OB-I00 to JA), and the “Severo Ochoa” grant of the National Agency for Research (AEI)- MCIU (Ref. CEX2021-001189-S to IATA-CSIC, CEX2021-001136-S to CIC bioGUNE). The predoctoral contract to A. T-M from MCIU is acknowledged. AP is supported by an MSCA Postdoctoral Fellowship (award number 101150747)., With funding from the Spanish government through the ‘Severo Ochoa Centre of Excellence’ accreditation (CEX2021-001189-S and CEX2021-001136-S)., Peer reviewed